This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The early intervention comprised a routine angiography, followed by revascularisation if clinically indicated, and this was compared with a conservative strategy, which comprised ischaemia or symptom-driven angiography.
Location/setting
UK/secondary care.
Methods

Analytical approach:
A decision tree determined the incidences of events during the trial hospitalisation period and these incidences supplied a Markov model tracking the health status of patients, over a lifetime horizon. The authors stated that the perspective was that of the UK health service.
Effectiveness data:
Most of the effectiveness data were derived from a randomised controlled trial (RCT) called the third Randomised Intervention Trial of Unstable Angina (RITA 3). These data were supplemented with data from life tables. The RITA 3 was a prospective, randomised, multi-centre trial, with 1,810 patients from 45 hospitals in England and Scotland. The length of follow-up was five years. The main clinical parameter was myocardial infarction or cardiovascular death. The risk of an event during the trial was calculated using logistic regression. The risk following discharge was extrapolated using a Weibull proportional hazards model.
Monetary benefit and utility valuations:
Quality-of-life estimates were collected from patients in the RITA 3 using the European Quality of life (EQ-5D) questionnaire.
Measure of benefit:
The summary measure of benefit was the quality-adjusted life-year (QALY) and these were discounted at an annual rate of 3.5%.
